I. Hansen

1.0k citations
12 papers · 424 · h-index 8

Impact in

  • Rheumatology top 2%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
    • Spondyloarthritis Studies and Treatments
    • Musculoskeletal synovial abnormalities and treatments
  • Hematology
    • Autoimmune and Inflammatory Disorders Research

Papers in

Co-authors
Anne Grethe Jurik (5 shared papers)Merete Lund Hetland (7 shared papers)Torkell Ellingsen (7 shared papers)Peter Junker (7 shared papers)Hanne Lindegaard (7 shared papers)Tine Lottenburger (6 shared papers)K. Stengaard‐Pedersen (6 shared papers)Ulrik Tarp (3 shared papers)
Journals
Annals of the Rheumatic Diseases (7 papers)Scandinavian Journal of Rheumatology (3 papers)European Journal of Clinical Microbiology & Infectious Diseases (1 paper)The Pharmacogenomics Journal (1 paper)
Partner nations
DenmarkNetherlands

In The Last Decade

I. Hansen

12 papers receiving 413 citations

Peers

I. Hansen
Comparison fields: 5 of 45
  • Rheumatology 309
  • Hematology 63
  • Genetics 19
  • Orthopedics and Sports Medicine 14
  • Cancer Research 24
Replace G. R. Burmester with:
G. R. Burmester Germany
Jacques‐Eric Gottenberg France
Jinxian Huang China
M Viana Queiróz Portugal
B. Haraoui Canada
L Bradbury United Kingdom
Rositsa Karalilova Bulgaria
Pietro Leccese Italy
Raphael Micheroli Switzerland
Nilgün Solak Tekin Türkiye
I. Hansen relative to G. R. Burmester Germany G. R. Burmester's profile →
Citations per field
00.5×2×3×
G. R. Burmester · 1×
Citations per year

Countries citing papers authored by I. Hansen

Since Specialization
Citations

This map shows the geographic impact of I. Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Hansen more than expected).

Fields of papers citing papers by I. Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Hansen. The network helps show where I. Hansen may publish in the future.

Co-authors

The 25 scholars most cited alongside I. Hansen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with I. Hansen Line = papers co-authored together I. Hansen links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1
Radiographic progression and remission rates in early rheumatoid arthritis – MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial
Annals of the Rheumatic Diseases ·Merete Lund Hetland, K. Stengaard‐Pedersen, Peter Junker, Mikkel Østergaard, B Ejbjerg, Søren Jacobsen, Tine Lottenburger, I. Hansen, Ulrik Tarp, (unknown), Anders Jørgen Svendsen, U. Birk Lauridsen, Torkell Ellingsen, Hanne Lindegaard, Jan Pødenphant, (unknown), Anne Grethe Jurik, Kim Hørslev‐Petersen
2010156
2
Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study
Annals of the Rheumatic Diseases ·Merete Lund Hetland, K. Stengaard‐Pedersen, Peter Junker, Tine Lottenburger, I. Hansen, Lis Smedegaard Andersen, Ulrik Tarp, Anders Jørgen Svendsen, (unknown), U. Birk Lauridsen, Torkell Ellingsen, G. Hansen, Hanne Lindegaard, A Vestergaard, Anne Grethe Jurik, (unknown), (unknown)
200791
3
Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis
The Pharmacogenomics Journal ·S. B. Krintel, Christian Dehlendorff, Merete Lund Hetland, (unknown), Klaus K. Andersen, Peter Junker, Jan Pødenphant, Torkell Ellingsen, Palle Ahlquist, Hanne Lindegaard, Asta Linauskas, A. Schlemmer, Mette Yde Dam, I. Hansen, Hans Christian Horn, Anne Jørgensen, Johnny Raun, Christian Gytz Ammitzbøll, Mikkel Østergaard, Kristian Stengaard‐Pedersen, Julia S. Johansen
201561
4
Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA)
Annals of the Rheumatic Diseases ·(unknown), Merete Lund Hetland, Lykke Midtbøll Ørnbjerg, Peter Junker, Jan Pødenphant, Torkell Ellingsen, Palle Ahlquist, Hanne Lindegaard, Asta Linauskas, A. Schlemmer, Mette Yde Dam, I. Hansen, Tine Lottenburger, Christian Gytz Ammitzbøll, Anne Jørgensen, S. B. Krintel, Johnny Raun, Julia S. Johansen, Mikkel Østergaard, K. Stengaard‐Pedersen
201534
5
Faecal calprotectin detects subclinical bowel inflammation and may predict treatment response in spondyloarthritis
Scandinavian Journal of Rheumatology ·René Østgård, Bent Deleuran, MY Dam, I. Hansen, Anne Grethe Jurik, Henning Glerup
201734
6
Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression
Scandinavian Journal of Rheumatology ·Torkell Ellingsen, I. Hansen, J Thorsen, B K Moller, Ulrik Tarp, Tine Lottenburger, LS Andersen, Henrik Skjødt, (unknown), U. Birk Lauridsen, Anders Jørgen Svendsen, Hanne Lindegaard, Søren Jacobsen, Mikkel Østergaard, A Vestergaard, Anne Grethe Jurik, Peter Junker, AF Christensen, Merete Lund Hetland, (unknown), K. Stengaard‐Pedersen
201320
7
Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation studies based on the CIMESTRA and OPERA trials
Scandinavian Journal of Rheumatology ·CH Brahe, Christian Dehlendorff, Mikkel Østergaard, JS Johansen, LM Ørnbjerg, (unknown), K. Stengaard‐Pedersen, Peter Junker, Torkell Ellingsen, Hanne Lindegaard, I. Hansen, Tine Lottenburger, Søren Jacobsen, Anne Grethe Jurik, Merete Lund Hetland
201811
8
Trend in Incidence and Case Fatality of Meningococcal Disease over 16 Years in Northern Denmark
European Journal of Clinical Microbiology & Infectious Diseases ·Henrik Toft Sørensen, Flemming Hald Steffensen, Henrik Carl Schønheyder, G. L. Nielsen, I. Hansen, Kreesten Meldgaard Madsen, H. J. Hamburger
19989
9
THU0212 Improved Remission Rates Acquired by Adding Adalimumab to Methotrexate and Intraarticular Glucocorticoid Cannot be Maintained after Withdrawal of Adalimumab. A 2-Year Investigator Initiated Randomised, Controlled Study on Early Rheumatoid Arthritis
Annals of the Rheumatic Diseases ·(unknown), Merete Lund Hetland, Peter Junker, Jan Pødenphant, Torkell Ellingsen, Palle Ahlqvist, Hanne Lindegaard, Asta Linauskas, A. Schlemmer, Mette Yde Dam, I. Hansen, Tine Lottenburger, Anne Jørgensen, S. B. Krintel, Johnny Raun, Christian Gytz Ammitzbøll, J.S. Johansen, Mikkel Østergaard, K. Stengaard‐Pedersen
20135
10
POS0700 METABOLIC AND MORPHOLOGIC PET/MR FEATURES IN CRANIAL GIANT CELL ARTERITIS
Annals of the Rheumatic Diseases ·P. H. Nienhuis, Christian Møller Sørensen, Kresten Krarup Keller, I. Hansen, Esben Uggerby Næser, M. Nyhuus Bendix Rasch, Elisabeth Brouwer, Riemer H. J. A. Slart, André H. Dias, Auke P.A. Appelman, Ellen‐Margrethe Hauge, Lars Christian Gormsen, Berit Dalsgaard Nielsen
20231
11
SAT0280 Prolonged Risk of Specific Malignancies following Cyclophosphamide-Therapy among Patients with Granulomatosis with Polyangiitis (WEGENER'S)
Annals of the Rheumatic Diseases ·Mikkel Faurschou, Lene Mellemkjær, Anne Voss, Kresten Krarup Keller, I. Hansen, Bo Baslund
20141
12
POS0399 DIAGNOSTIC PERFORMANCE OF HEAD AND NECK FDG-PET/MR IN NEW-ONSET GCA
Annals of the Rheumatic Diseases ·P. H. Nienhuis, André H. Dias, Christian Møller Sørensen, K. Keller, I. Hansen, Esben Uggerby Næser, M. Nyhuus Bendix Rasch, Auke P.A. Appelman, Elisabeth Brouwer, Riemer H. J. A. Slart, Ellen‐Margrethe Hauge, Lars Christian Gormsen, Berit Dalsgaard Nielsen
20241

About I. Hansen

I. Hansen is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 12 papers that have together received 424 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (6 papers), Multiple and Secondary Primary Cancers (1 paper), Acute Myeloid Leukemia Research (1 paper), Traumatic Brain Injury and Neurovascular Disturbances (1 paper), S100 Proteins and Annexins (1 paper), Vasculitis and related conditions (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Spondyloarthritis Studies and Treatments (1 paper). The work is most often cited by research in Rheumatology (309 citations), Hematology (63 citations), Genetics (19 citations), Orthopedics and Sports Medicine (14 citations) and Cancer Research (24 citations). I. Hansen has collaborated with scholars based in Denmark and Netherlands. Frequent co-authors include Anne Grethe Jurik, Merete Lund Hetland, Torkell Ellingsen, Peter Junker, Hanne Lindegaard, Tine Lottenburger, K. Stengaard‐Pedersen, Ulrik Tarp, Anders Jørgen Svendsen and Mikkel Østergaard. Their work appears in journals such as Annals of the Rheumatic Diseases, Scandinavian Journal of Rheumatology, European Journal of Clinical Microbiology & Infectious Diseases and The Pharmacogenomics Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. R. BurmesterBreakdown of academic impact, for papers by Jacques‐Eric GottenbergBreakdown of academic impact, for papers by Jinxian HuangBreakdown of academic impact, for papers by M Viana QueirózBreakdown of academic impact, for papers by B. HaraouiBreakdown of academic impact, for papers by L BradburyBreakdown of academic impact, for papers by Rositsa KaralilovaBreakdown of academic impact, for papers by Pietro LecceseBreakdown of academic impact, for papers by Raphael MicheroliBreakdown of academic impact, for papers by Nilgün Solak Tekin